Spectaire Closes $2.0 Million Equity Investment
March 21, 2024
WATERTOWN, Mass. -- Spectaire Holdings Inc. (NASDAQ: SPEC) (“Spectaire”) has announced that it has closed a $2.0 million private placement with True Remainders Ltd. for the sale and issuance of (i) an aggregate of 1,538,461 shares of Spectaire common stock, and (ii) an accompanying warrant to purchase up to 1,538,461 shares of Spectaire common stock [...]
March 20, 2024
Significant throughput of LSA to advance IPA’s diversity- and data-driven drug development and to enrich LENSai™. VICTORIA, British Columbia -- IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today announced that it has acquired the LSA® instrument platform from Carterra®, a leading provider of high-throughput large [...]
METTLER TOLEDO Launches New Generation of Laboratory Balances
March 20, 2024
METTLER TOLEDO positions itself at the forefront of laboratory weighing when it comes to simplicity, performance, and robustness. COLUMBUS, Ohio – With the introduction of the new Advanced and Standard Balance portfolio, including MX, MR, MA and LA lines, METTLER TOLEDO positions itself at the forefront of laboratory weighing when it comes to simplicity, performance, [...]
Synthace Announces Appointment of Willem Baralt as New Chairman
March 20, 2024
LONDON and BOSTON -- Synthace, the leading digital experiment platform for life science R&D, today announced the appointment of Willem Baralt as its new Chairman of the Board. Mr. Baralt joined the company in February 2024 during a period of accelerating growth, as Synthace expands its offerings. "I am thrilled to welcome Willem aboard," said Guy Levy-Yurista, PhD, CEO of Synthace. "His addition marks [...]
SPECTRO Introduces New Generation SPECTROCHECK LMM02 Stationary Metal Analyzer
March 20, 2024
SPECTRO introduces its newest SPECTROCHECK LMM02 Stationary Metal Analyzer — the affordable solution to meet the performance demands and budgets of small foundries, automotive suppliers, and other metal fabricators. The latest generation SPECTROCHECK analyzer delivers the industry-leading combination of an even lower cost of ownership with continued precision, stability, reliability, and unparalleled analytical performance —at [...]
Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group
March 20, 2024
Asserts CSG has acted in bad faith, ignoring obligations as strategic partner for Spotfire® software WALTHAM, Mass. -- Today, Revvity, Inc. (NYSE: RVTY) announced that it has filed a complaint against Cloud Software Group (CSG) in Massachusetts Superior Court and requested injunctive relief to enforce Revvity’s rights and CSG’s obligations as a strategic partner. CSG is refusing [...]
Merck Invests More Than € 300 Million in New Life Science Production Site in South Korea
March 20, 2024
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics. Site to supply products to customers for development and production of biologics New Bioprocessing Production Center in Daejeon strengthens footprint of Merck in fast-growing Asia-Pacific region Investment to create up to 300 additional jobs DARMSTADT, GERMANY [...]
Elegen Launches ENFINIA™ DNA Enhancement for Rapid Synthesis of Highly Complex DNA
March 20, 2024
Following successful, fully subscribed Early Access and Beta Programs, Elegen’s latest ENFINIA™ DNA enhancement provides access to very challenging sequences, including long repeats and STRs, GC-rich promoters, enhancers, terminators, ITRs, LTRs and homopolymers. Elegen is the only DNA manufacturer delivering the unique combination of industry-leading complexity, length and NGS-verified accuracy within days, streamlining workflows and [...]
March 20, 2024
Development of next-generation sequencing companion diagnostics (CDx) Goal is to help increase patient access to Bayer’s precision cancer therapies by offering decentralized genomic testing and rapid turnaround time BERLIN & CARLSBAD, Calif. -- Bayer AG and Thermo Fisher Scientific Inc. today announced to develop next-generation sequencing (NGS)-based companion diagnostic assays (CDx) together. These will help [...]
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
March 20, 2024
HERCULES, Calif. -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Roop K. Lakkaraju will join the company as its new Executive Vice President and Chief Financial Officer, effective April 15, 2024. Mr. Lakkaraju joins Bio-Rad from Benchmark Electronics, a multi-national leader [...]

